Novoteris is a privately held limited liabilities corporation that is managed by a group of international industry veterans and clinicians involved in developing and producing innovative, cutting-edge medical products.
News from Novoteris:
GARDEN GROVE, Calif., June 23, 2015 /PRNewswire/ — Novoteris, LLC announced today a $2.8 million agreement with Cystic Fibrosis Foundation Therapeutics Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, to develop an inhaled nitric oxide antimicrobial therapy for people with cystic fibrosis (CF) who have airway bacterial colonization. Logo – http://photos.prnewswire.com/prnh/20150622/224600LOGO […]
Application Brings Years of Work with Nitric Oxide Gas for Antimicrobial Use to Clinical Fruition GARDEN GROVE, Calif., Oct. 9, 2013 /PRNewswire/ — Novoteris, LLC., a clinical stage medical device and pharmaceutical developer focused on innovative applications for nitric oxide gas where it can be applied for unmet medical needs, announced today that the Office of […]
